Pacira Biosciences, Stock Analysis

Pacira Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pacira BioSciences, recorded a loss per share of 2.15. The entity had not issued any dividends in recent years. Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. Pacira Pharm operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 697 people. To find out more about Pacira BioSciences, contact David Stack at 813 553 6680 or learn more at https://www.pacira.com.

Pacira BioSciences, Investment Alerts

Pacira BioSciences, Upcoming and Recent Events

Pacira Largest EPS Surprises

View All Earnings Estimates

Pacira BioSciences, Environmental, Social, and Governance (ESG) Scores

Pacira Stock Institutional Investors

Note, although Pacira BioSciences,'s institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pacira Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.15 B.

Pacira Profitablity

The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Management Efficiency

Pacira BioSciences, has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1208) %, meaning that it created substantial loss on money invested by shareholders. Pacira BioSciences,'s management efficiency ratios could be used to measure how well Pacira BioSciences, manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.09 in 2025. Return On Capital Employed is likely to drop to -0.06 in 2025. At this time, Pacira BioSciences,'s Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 241.3 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 414.1 M in 2025.

Technical Drivers

As of the 24th of March, Pacira BioSciences, holds the Risk Adjusted Performance of 0.1277, coefficient of variation of 746.39, and Semi Deviation of 2.2. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pacira BioSciences,, as well as the relationship between them.

Pacira BioSciences, Price Movement Analysis

Pacira BioSciences, Insider Trading Activities

Pacira BioSciences, Outstanding Bonds

Pacira BioSciences, Predictive Daily Indicators

Pacira BioSciences, Corporate Filings

Pacira BioSciences, Forecast Models

Pacira BioSciences,'s time-series forecasting models are one of many Pacira BioSciences,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pacira BioSciences,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pacira BioSciences, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pacira shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pacira BioSciences,. By using and applying Pacira Stock analysis, traders can create a robust methodology for identifying Pacira entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pacira analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pacira analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pacira BioSciences, stock analysis indicators help investors evaluate how Pacira BioSciences, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pacira BioSciences, shares will generate the highest return on investment. By understating and applying Pacira BioSciences, stock analysis, traders can identify Pacira BioSciences, position entry and exit signals to maximize returns.

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.